13
Participants
Start Date
September 17, 2019
Primary Completion Date
February 2, 2021
Study Completion Date
March 2, 2021
KB195
KB195 is a novel glycan
Cliniques Universitaires Saint-Luc, Brussels
Inselpital, Universitaetsklinik fur Kinderheikunde, Bern
Inselpital, Universitätsklinik für Kinderheilkunde, Bern
Universitair Ziekenhuis Gent, Ghent
Icahn School of Medicine at Mount Sinai-Clinical Research Unit, New York
Johns Hopkins University School of Medicine, Baltimore
Hospital Universitario Reina Sofia, Córdoba
UPMC Children's Hospital of Pittsburgh, Pittsburgh
Children's National Medical Center, Washington D.C.
University of South Florida/ USF HEALTH, Tampa
Hospital Universitario Virgen del Rocio, Seville
Hospital de Cruces, Barakaldo
Washington University School of Medicine, St Louis
Zentrum für Kinder- und Jugendmedizin Angelika-Lautenschläger-Klinik, Heidelberg
Hosptial Universitari Vall d'Hebron, Barcelona
Department of Child Health and Diseases, Department of Nutrition and Metabolism Istanbul University, Istanbul
Salford Royal Hospital, Salford
Salford Royal NHS Foundation Trust, Salford
National Hospital for Neurology and Neurosurgery, London
Lead Sponsor
Kaleido Biosciences
INDUSTRY